Related Experiment Video
Updated: Mar 21, 2026

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
Cytopathologic characteristics of SMARCB1 (INI-1) deficient sinonasal carcinoma: A potential diagnostic pitfall
Derek B Allison1, Justin A Bishop1, Syed Z Ali1
1Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Abstract:
Tumors of the head and neck are extremely diverse and a subset are poorly differentiated and difficult to classify. Recently, a new entity has been described with rhabdoid and/or plasmacytoid cytologic features and a characteristic genetic signature-inactivation of the SMARCB1 (INI-1) tumor suppressor gene. To date, only 16 cases of SMARCB1 (INI-1) deficient sinonasal carcinoma have been described, and there are currently no reports of the cytopathologic features by fine needle aspiration (FNA) cytology. A case of a 77-year-old man who presented with a posterior ethmoid sinus lesion with invasion into the skull base and bone was reported. FNA cytology of a right retropharyngeal lymph node revealed relatively monomorphic, loosely cohesive clusters of plasmacytoid cells with occasional nucleoli, rare intranuclear cytoplasmic inclusions, and mitotic figures in a background of necrosis and absence of overt squamous or glandular differentiation. A diagnosis of metastatic myoepithelial carcinoma was made; however, retrospectively, the surgical excision showed loss of the SMARCB1 (INI-1) tumor suppressor gene by immunohistochemistry. In summary, the cytomorphologic features of SMARCB1 (INI-1) deficient sinonasal carcinoma are relatively nonspecific and overlap with other regional tumors, including myoepithelial neoplasms. As a result, this entity should be considered in the differential diagnosis for a plasmacytoid tumor arising in the sinonasal tract by FNA cytology. Diagn. Cytopathol. 2016;44:700-703. © 2016 Wiley Periodicals, Inc.
Insights
SMARCB1 (INI-1) deficient sinonasal carcinoma presents with non-specific features on fine needle aspiration cytology. This rare tumor, characterized by plasmacytoid cells, requires consideration in differential diagnoses for sinonasal tract lesions.
Area of Science:
- Oncology
- Cytopathology
- Genetics
Background:
- Head and neck tumors are diverse, with some poorly differentiated and difficult to classify.
- A subset exhibits rhabdoid/plasmacytoid features and SMARCB1 (INI-1) gene inactivation.
- SMARCB1 (INI-1) deficient sinonasal carcinoma is a recently described entity with limited case reports.
Observation:
- Fine needle aspiration (FNA) cytology of a retropharyngeal lymph node revealed plasmacytoid cells.
- The cells showed monomorphism, loose cohesion, occasional nucleoli, and mitotic figures.
- A background of necrosis was present, with no overt squamous or glandular differentiation.
Findings:
- Initial diagnosis was metastatic myoepithelial carcinoma based on FNA findings.
- Retrospective analysis of surgical excision confirmed loss of SMARCB1 (INI-1) tumor suppressor gene expression via immunohistochemistry.
- Cytomorphologic features of SMARCB1 (INI-1) deficient sinonasal carcinoma are nonspecific and mimic other regional tumors.
Implications:
- SMARCB1 (INI-1) deficient sinonasal carcinoma should be included in the differential diagnosis for plasmacytoid tumors of the sinonasal tract.
- Accurate cytopathologic diagnosis is crucial for appropriate patient management.
- Further research is needed to define the specific cytopathologic criteria for this rare entity.
More Related Videos
Related Concept Videos
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

